Dr. Saikrishna S. Yendamuri

Claim this profile

Roswell Park Cancer Institute

Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
4 reported clinical trials
5 drugs studied

Area of expertise

1Lung Cancer
Saikrishna S. Yendamuri has run 3 trials for Lung Cancer. Some of their research focus areas include:
Stage I
Stage II
Stage III
2Non-Small Cell Lung Cancer
Saikrishna S. Yendamuri has run 2 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Stage I
Stage II

Affiliated Hospitals

Image of trial facility.
Roswell Park Cancer Institute

Clinical Trials Saikrishna S. Yendamuri is currently running

Image of trial facility.

Pre-Surgical Respiratory Muscle Training

for Lung Cancer

This phase II trial studies how well respiratory muscle training before surgery works in preventing lung complications after surgery in patients with stage I-IIIB lung cancer. Patients with lung cancer who choose to undergo surgical resection often have complications after surgery such as pneumonia, unplanned intubations, difficulty breathing and reduced physical functioning, and increased medical costs and a reduced quality of life. Improving pre-surgical pulmonary health through respiratory muscle training may improve respiratory muscle strength, response to surgery, and quality of life after surgery in patients with lung cancer.
Recruiting1 award Phase 26 criteria
Image of trial facility.

Metformin

for Lung Cancer Prevention in Overweight or Obese Individuals

This phase II trial determines the effect of metformin extended release on the risk for developing lung cancer in overweight/obese patients that are at high-risk for developing lung cancer. Metformin is widely used to treat type II diabetes and has a long history of safety and minimal side effects. At similar dosage, the drug may have potential anti-cancer activity. Metformin use has been associated with improved survival in patients with non-small cell lung carcinoma, a specific type of lung cancer, and it has also been shown to enhance immune mobilization against tumors. This trial aims to see whether metformin extended release as a preventative treatment may lower the chance of developing lung cancer, and whether it may help patients' immune system learn ("reprogram") to lower a certain type of immune cell (called regulatory T cells) that are linked to tumor development.
Recruiting1 award Phase 215 criteria

More about Saikrishna S. Yendamuri

Clinical Trial Related6 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Saikrishna S. Yendamuri has experience with
  • Porfimer Sodium
  • Light Dosimetry
  • Light Dosimetry For Intranoperative Therapy
  • Respiratory Muscle Training
  • Metformin

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Saikrishna S. Yendamuri specialize in?
Saikrishna S. Yendamuri focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage I patients, or patients who are Stage II.
Is Saikrishna S. Yendamuri currently recruiting for clinical trials?
Yes, Saikrishna S. Yendamuri is currently recruiting for 2 clinical trials in Buffalo New York. If you're interested in participating, you should apply.
Are there any treatments that Saikrishna S. Yendamuri has studied deeply?
Yes, Saikrishna S. Yendamuri has studied treatments such as Porfimer Sodium, Light Dosimetry, Light Dosimetry for Intranoperative Therapy.
What is the best way to schedule an appointment with Saikrishna S. Yendamuri?
Apply for one of the trials that Saikrishna S. Yendamuri is conducting.
What is the office address of Saikrishna S. Yendamuri?
The office of Saikrishna S. Yendamuri is located at: Roswell Park Cancer Institute, Buffalo, New York 14263 United States. This is the address for their practice at the Roswell Park Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.